PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 2128003
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 2128003
Bleeding Disorder Testing Market Size, Share, Growth, Global Industry Analysis, Regional Insights and Forecast to 2026-2034
Growth Factors of bleeding disorders testing Market
The global bleeding disorders testing market was valued at USD 109.8 million in 2025 and is projected to grow from USD 118.39 million in 2026 to USD 222.20 million by 2034, registering a CAGR of 8.19% during the forecast period. Europe accounted for the largest market share of 40.25% in 2025, supported by advanced healthcare infrastructure, strong diagnostic adoption, and increasing awareness of inherited bleeding disorders.
Bleeding disorders, including hemophilia A, hemophilia B, Von Willebrand disease, and idiopathic thrombocytopenic purpura, require timely diagnosis to prevent severe complications. The growing prevalence of these disorders, coupled with technological advancements in laboratory diagnostics, is driving the demand for specialized testing solutions worldwide. Continuous improvements in automated analyzers, reagents, and AI-assisted diagnostic platforms are further strengthening market expansion.
Market Trends
Integration of Artificial Intelligence and Advanced Diagnostic Technologies Driving Market Growth
The bleeding disorders testing market is witnessing rapid technological transformation with the integration of artificial intelligence (AI), machine learning (ML), and automated laboratory systems. AI-powered diagnostic platforms improve the accuracy of disease detection while reducing testing time and human errors. Additionally, innovations in nanotechnology-based diagnostics and high-throughput analyzers are enabling laboratories to perform faster and more reliable coagulation testing.
Leading manufacturers are also introducing advanced hemostasis analyzers and automated diagnostic solutions to enhance workflow efficiency in hospitals and diagnostic laboratories.
Market Drivers
Rising Prevalence of Bleeding Disorders Boosting Testing Demand
The increasing incidence of inherited bleeding disorders remains one of the strongest growth drivers for the market. According to global healthcare organizations, the number of diagnosed patients with hemophilia and Von Willebrand disease continues to rise due to improved awareness and better screening programs. Governments, healthcare organizations, and patient advocacy groups are actively promoting early diagnosis through awareness campaigns and updated clinical guidelines.
Growing investments in healthcare infrastructure, particularly across emerging economies, are further expanding access to diagnostic testing services.
Continuous Product Innovation Supporting Market Expansion
Diagnostic manufacturers are investing significantly in research and development to introduce advanced coagulation analyzers, testing kits, and consumables. Automation technologies, portable diagnostic devices, and digital laboratory solutions are improving testing efficiency while reducing operational costs. Strategic collaborations between diagnostic companies and healthcare providers are also accelerating product commercialization and expanding market reach.
Market Restraints
Limited Testing Penetration in Emerging Economies Restrains Growth
Despite increasing awareness, many developing countries continue to experience low diagnostic penetration due to inadequate healthcare infrastructure, limited reimbursement policies, and insufficient laboratory facilities. High costs associated with advanced testing instruments and reagents also restrict adoption in resource-constrained healthcare systems. In addition, inconsistent adherence to international diagnostic guidelines remains a major challenge in several emerging markets.
Segment Analysis
By Product Type
Based on product type, the market is segmented into reagents & consumables and instruments.
The reagents & consumables segment is expected to dominate the market with a 69.34% share in 2026, supported by increasing testing volumes and continuous demand for diagnostic consumables across laboratories. Meanwhile, the instruments segment is projected to witness steady growth due to increasing adoption of automated coagulation analyzers and technological advancements.
By Indication
Based on indication, the market includes hemophilia A, Von Willebrand disease, hemophilia B, idiopathic thrombocytopenic purpura, and others.
The hemophilia A segment is projected to account for the largest market share of 46.19% in 2026, driven by its relatively higher prevalence and growing awareness regarding early diagnosis. Increasing adoption of advanced coagulation testing technologies is also supporting growth across other disease segments.
By End User
Based on end user, the market is categorized into hospitals & clinics, diagnostic centers, and others.
The hospitals & clinics segment is expected to dominate the market with a 60.31% share in 2026, owing to increasing patient admissions, wider availability of diagnostic facilities, and growing implementation of advanced laboratory equipment. Diagnostic centers are anticipated to register the fastest growth during the forecast period due to rising outpatient diagnostic services and technological advancements.
Regional Analysis
Europe
Europe remained the leading regional market with a value of USD 44.2 million in 2025 and is expected to reach USD 47.75 million in 2026. Strong healthcare infrastructure, established diagnostic guidelines, and increasing prevalence of bleeding disorders continue to support regional growth. The U.K. market is projected to reach USD 16.24 million in 2026, while Germany is expected to reach USD 7.07 million.
North America
North America generated USD 31.87 million in 2025 and is projected to reach USD 34.13 million in 2026. Rising regulatory approvals, growing adoption of automated testing technologies, and increasing awareness programs are driving regional demand. The U.S. market is expected to reach USD 28.98 million in 2026.
Rest of the World
The Rest of the World market accounted for USD 6.9 million in 2025 and is projected to grow to USD 7.3 million in 2026. Improving healthcare infrastructure, expanding diagnostic capabilities, and increasing awareness initiatives across Asia Pacific, the Middle East, and other emerging regions are supporting market growth. China is expected to reach USD 17.42 million, Japan USD 3.85 million, and India USD 3.06 million in 2026.
Competitive Landscape
The global bleeding disorders testing market is moderately fragmented, with leading companies focusing on product innovation, automation, strategic partnerships, and regional expansion. Continuous investments in research and development are helping manufacturers strengthen their diagnostic portfolios and improve testing efficiency.
Major companies operating in the market include F. Hoffmann-La Roche Ltd., Siemens Healthcare GmbH, HORIBA Ltd., Sysmex Corporation, Abbott, Thermo Fisher Scientific Inc., Atlas Medical GmbH, HYPHEN BioMed, and Precision Biologics.
Key Industry Developments
- July 2022: HORIBA Ltd. expanded its Yumizen H500 and H550 hematology product family with enhanced performance and new features.
- February 2022: Sysmex Corporation established Sysmex LLC in Saudi Arabia to strengthen its hematology and hemostasis business.
- November 2021: Precision BioLogic introduced CRYOcheck Factor VIII Deficient Plasma with VWF across several international markets.
- August 2021: Siemens Healthcare GmbH launched Sysmex CN-3000 and CN-6000 Hemostasis Systems for medium- and high-volume coagulation testing.
- March 2021: F. Hoffmann-La Roche introduced eight new Cobas Pro integrated solution configurations to improve laboratory throughput and testing efficiency.
Conclusion
The global bleeding disorders testing market is expected to witness strong growth through 2034, supported by the increasing prevalence of inherited bleeding disorders, growing awareness regarding early diagnosis, and continuous technological advancements in diagnostic testing. Rising adoption of automated analyzers, AI-powered diagnostic platforms, and advanced coagulation testing systems will further accelerate market expansion. As healthcare infrastructure continues to improve across both developed and emerging economies, demand for accurate, efficient, and accessible bleeding disorder testing solutions is expected to remain robust throughout the forecast period.
Segmentation By Product Type
- Reagents & Consumables
- Instruments
By Indication
- Hemophilia A
- Hemophilia B
- Von Willebrand Disease
- Idiopathic Thrombocytopenic Purpura
- Others
By End-user
- Hospitals & Clinics
- Diagnostic Centers
- Others
By Geography
- North America (U.S. and Canada)
- Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and the Rest of Europe)
- Asia Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia Pacific)
- Rest of the World
Table of Content
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Trends
4. Key Insights
- 4.1. Prevalence of Bleeding Disorders, by Key Countries, 2025
- 4.2. New Product Launches, By Key Players
- 4.3. Technological Advancements in the Global Bleeding Disorders Testing Market
- 4.4. Impact of COVID-19 on the Market
5. Global Bleeding Disorders Testing Market Analysis, Insights and Forecast, 2021-2034
- 5.1. Market Analysis, Insights and Forecast - By Product Type
- 5.1.1. Reagents & Consumables
- 5.1.2. Instruments
- 5.2. Market Analysis, Insights and Forecast - By Indication
- 5.2.1. Hemophilia A
- 5.2.2. Hemophilia B
- 5.2.3. Von Willebrand Disease
- 5.2.4. Idiopathic Thrombocytopenic Purpura (ITP)
- 5.2.5. Others
- 5.3. Market Analysis, Insights and Forecast - By End-user
- 5.3.1. Hospitals & Clinics
- 5.3.2. Diagnostic Centers
- 5.3.3. Others
- 5.4. Market Analysis, Insights and Forecast - By Region
- 5.4.1. North America
- 5.4.2. Europe
- 5.4.3. Asia Pacific
- 5.4.4. Rest of the World
6. North America Bleeding Disorders Testing Market Analysis, Insights and Forecast, 2021-2034
- 6.1. Market Analysis, Insights and Forecast - By Product Type
- 6.1.1. Reagents & Consumables
- 6.1.2. Instruments
- 6.2. Market Analysis, Insights and Forecast - By Indication
- 6.2.1. Hemophilia A
- 6.2.2. Hemophilia B
- 6.2.3. Von Willebrand Disease
- 6.2.4. Idiopathic Thrombocytopenic Purpura (ITP)
- 6.2.5. Others
- 6.3. Market Analysis, Insights and Forecast - By End-user
- 6.3.1. Hospitals & Clinics
- 6.3.2. Diagnostic Centers
- 6.3.3. Others
- 6.4. Market Analysis, Insights and Forecast - By Country
- 6.4.1. U.S.
- 6.4.2. Canada
7. Europe Bleeding Disorders Testing Market Analysis, Insights and Forecast, 2021-2034
- 7.1. Market Analysis, Insights and Forecast - By Product Type
- 7.1.1. Reagents & Consumables
- 7.1.2. Instruments
- 7.2. Market Analysis, Insights and Forecast - By Indication
- 7.2.1. Hemophilia A
- 7.2.2. Hemophilia B
- 7.2.3. Von Willebrand Disease
- 7.2.4. Idiopathic Thrombocytopenic Purpura (ITP)
- 7.2.5. Others
- 7.3. Market Analysis, Insights and Forecast - By End-user
- 7.3.1. Hospitals & Clinics
- 7.3.2. Diagnostic Centers
- 7.3.3. Others
- 7.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
- 7.4.1. U.K
- 7.4.2. Germany
- 7.4.3. France
- 7.4.4. Spain
- 7.4.5. Italy
- 7.4.6. Scandinavia
- 7.4.7. Rest of Europe
8. Asia Pacific Bleeding Disorders Testing Market Analysis, Insights and Forecast, 2021-2034
- 8.1. Market Analysis, Insights and Forecast - By Product Type
- 8.1.1. Reagents & Consumables
- 8.1.2. Instruments
- 8.2. Market Analysis, Insights and Forecast - By Indication
- 8.2.1. Hemophilia A
- 8.2.2. Hemophilia B
- 8.2.3. Von Willebrand Disease
- 8.2.4. Idiopathic Thrombocytopenic Purpura (ITP)
- 8.2.5. Others
- 8.3. Market Analysis, Insights and Forecast - By End-user
- 8.3.1. Hospitals & Clinics
- 8.3.2. Diagnostic Centers
- 8.3.3. Others
- 8.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
- 8.4.1. Japan
- 8.4.2. China
- 8.4.3. India
- 8.4.4. Australia
- 8.4.5. Southeast Asia
- 8.4.6. Rest of Asia Pacific
9. Rest of the World Bleeding Disorders Testing Market Analysis, Insights and Forecast, 2021-2034
- 9.1. Market Analysis, Insights and Forecast - By Product Type
- 9.1.1. Reagents & Consumables
- 9.1.2. Instruments
- 9.2. Market Analysis, Insights and Forecast - By Indication
- 9.2.1. Hemophilia A
- 9.2.2. Hemophilia B
- 9.2.3. Von Willebrand Disease
- 9.2.4. Idiopathic Thrombocytopenic Purpura (ITP)
- 9.2.5. Others
- 9.3. Market Analysis, Insights and Forecast - By End-user
- 9.3.1. Hospitals & Clinics
- 9.3.2. Diagnostic Centers
- 9.3.3. Others
10. Competitive Analysis
- 10.1. Global Market Share Analysis (2025)
- 10.2. Company Profiles
- 10.2.1. Siemens Healthcare GmbH
- 10.2.1.1. Overview
- 10.2.1.2. Product
- 10.2.1.3. SWOT Analysis
- 10.2.1.4. Recent Developments
- 10.2.1.5. Strategies
- 10.2.1.6. financials (Based on Availability)
- 10.2.2. F. Hoffmann-La Roche Ltd.
- 10.2.2.1. Overview
- 10.2.2.2. Product
- 10.2.2.3. SWOT Analysis
- 10.2.2.4. Recent Developments
- 10.2.2.5. Strategies
- 10.2.2.6. financials (Based on Availability)
- 10.2.3. Thermo Fisher Scientific Inc.
- 10.2.3.1. Overview
- 10.2.3.2. Product
- 10.2.3.3. SWOT Analysis
- 10.2.3.4. Recent Developments
- 10.2.3.5. Strategies
- 10.2.3.6. financials (Based on Availability)
- 10.2.4. Abbott Laboratories
- 10.2.4.1. Overview
- 10.2.4.2. Product
- 10.2.4.3. SWOT Analysis
- 10.2.4.4. Recent Developments
- 10.2.4.5. Strategies
- 10.2.4.6. financials (Based on Availability)
- 10.2.5. Atlas Medical GmbH
- 10.2.5.1. Overview
- 10.2.5.2. Product
- 10.2.5.3. SWOT Analysis
- 10.2.5.4. Recent Developments
- 10.2.5.5. Strategies
- 10.2.5.6. financials (Based on Availability)
- 10.2.6. HORIBA, Ltd.
- 10.2.6.1. Overview
- 10.2.6.2. Product
- 10.2.6.3. SWOT Analysis
- 10.2.6.4. Recent Developments
- 10.2.6.5. Strategies
- 10.2.6.6. financials (Based on Availability)
- 10.2.7. Sysmex Corporation
- 10.2.7.1. Overview
- 10.2.7.2. Product
- 10.2.7.3. SWOT Analysis
- 10.2.7.4. Recent Developments
- 10.2.7.5. Strategies
- 10.2.7.6. financials (Based on Availability)
- 10.2.8. HYPHEN BioMed
- 10.2.8.1. Overview
- 10.2.8.2. Product
- 10.2.8.3. SWOT Analysis
- 10.2.8.4. Recent Developments
- 10.2.8.5. Strategies
- 10.2.8.6. financials (Based on Availability)
- 10.2.9. Precision BioLogic Incorporated
- 10.2.9.1. Overview
- 10.2.9.2. Product
- 10.2.9.3. SWOT Analysis
- 10.2.9.4. Recent Developments
- 10.2.9.5. Strategies
- 10.2.9.6. financials (Based on Availability)
- 10.2.10. Other Players
- 10.2.1. Siemens Healthcare GmbH
List of Tables
- Table 1: Global Bleeding Disorders Testing Market Revenue (USD million) Forecast, by Product Type, 2021-2034
- Table 2: Global Bleeding Disorders Testing Market Revenue (USD million) Forecast, by Indication, 2021-2034
- Table 3: Global Bleeding Disorders Testing Market Revenue (USD million) Forecast, by End-user, 2021-2034
- Table 4: Global Bleeding Disorders Testing Market Revenue (USD million) Forecast, by Region, 2021-2034
- Table 5: North America Bleeding Disorders Testing Market Revenue (USD million) Forecast, by Product Type, 2021-2034
- Table 6: North America Bleeding Disorders Testing Market Revenue (USD million) Forecast, by Indication, 2021-2034
- Table 7: North America Bleeding Disorders Testing Market Revenue (USD million) Forecast, by End-user, 2021-2034
- Table 8: North America Bleeding Disorders Testing Market Revenue (USD million) Forecast, By Country, 2021-2034
- Table 9: Europe Bleeding Disorders Testing Market Revenue (USD million) Forecast, by Product Type, 2021-2034
- Table 10: Europe Bleeding Disorders Testing Market Revenue (USD million) Forecast, by Indication, 2021-2034
- Table 11: Europe Bleeding Disorders Testing Market Revenue (USD million) Forecast, by End-user, 2021-2034
- Table 12: Europe Bleeding Disorders Testing Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
- Table 13: Asia Pacific Bleeding Disorders Testing Market Revenue (USD million) Forecast, by Product Type, 2021-2034
- Table 14: Asia Pacific Bleeding Disorders Testing Market Revenue (USD million) Forecast, by Indication, 2021-2034
- Table 15: Asia Pacific Bleeding Disorders Testing Market Revenue (USD million) Forecast, by End-user, 2021-2034
- Table 16: Asia Pacific Bleeding Disorders Testing Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
- Table 17: Rest of the World Bleeding Disorders Testing Market Revenue (USD million) Forecast, by Product Type, 2021-2034
- Table 18: Rest of the World Bleeding Disorders Testing Market Revenue (USD million) Forecast, by Indication, 2021-2034
- Table 19: Rest of the World Bleeding Disorders Testing Market Revenue (USD million) Forecast, by End-user, 2021-2034
List of Figures
- Figure 1: Global Bleeding Disorders Testing Market Revenue Breakdown (USD million, %) by Region, 2025 & 2034
- Figure 2: Global Bleeding Disorders Testing Market Value Share (%), by Product Type, 2025 & 2034
- Figure 3: Global Bleeding Disorders Testing Market Value Share (%), by Indication, 2025 & 2034
- Figure 4: Global Bleeding Disorders Testing Market Value Share (%), by End-user, 2025 & 2034
- Figure 5: Global Bleeding Disorders Testing Market Value (USD million), by Region, 2025 & 2034
- Figure 6: North America Bleeding Disorders Testing Market Value (USD million), by Product Type, 2025 & 2034
- Figure 7: North America Bleeding Disorders Testing Market Value Share (%), by Product Type, 2025
- Figure 8: North America Bleeding Disorders Testing Market Value (USD million), by Indication, 2025 & 2034
- Figure 9: North America Bleeding Disorders Testing Market Value Share (%), by Indication, 2025
- Figure 10: North America Bleeding Disorders Testing Market Value (USD million), by End-user, 2025 & 2034
- Figure 11: North America Bleeding Disorders Testing Market Value Share (%), by End-user, 2025
- Figure 12: North America Bleeding Disorders Testing Market Value (USD million), By Country, 2025 & 2034
- Figure 13: North America Bleeding Disorders Testing Market Value Share (%), By Country, 2025
- Figure 14: Europe Bleeding Disorders Testing Market Value (USD million), by Product Type, 2025 & 2034
- Figure 15: Europe Bleeding Disorders Testing Market Value Share (%), by Product Type, 2025
- Figure 16: Europe Bleeding Disorders Testing Market Value (USD million), by Indication, 2025 & 2034
- Figure 17: Europe Bleeding Disorders Testing Market Value Share (%), by Indication, 2025
- Figure 18: Europe Bleeding Disorders Testing Market Value (USD million), by End-user, 2025 & 2034
- Figure 19: Europe Bleeding Disorders Testing Market Value Share (%), by End-user, 2025
- Figure 20: Europe Bleeding Disorders Testing Market Value (USD million), By Country/ Sub-region, 2025 & 2034
- Figure 21: Europe Bleeding Disorders Testing Market Value Share (%), By Country/ Sub-region, 2025
- Figure 22: Asia Pacific Bleeding Disorders Testing Market Value (USD million), by Product Type, 2025 & 2034
- Figure 23: Asia Pacific Bleeding Disorders Testing Market Value Share (%), by Product Type, 2025
- Figure 24: Asia Pacific Bleeding Disorders Testing Market Value (USD million), by Indication, 2025 & 2034
- Figure 25: Asia Pacific Bleeding Disorders Testing Market Value Share (%), by Indication, 2025
- Figure 26: Asia Pacific Bleeding Disorders Testing Market Value (USD million), by End-user, 2025 & 2034
- Figure 27: Asia Pacific Bleeding Disorders Testing Market Value Share (%), by End-user, 2025
- Figure 28: Asia Pacific Bleeding Disorders Testing Market Value (USD million), By Country/ Sub-region, 2025 & 2034
- Figure 29: Asia Pacific Bleeding Disorders Testing Market Value Share (%), By Country/ Sub-region, 2025
- Figure 30: Rest of the World Bleeding Disorders Testing Market Value (USD million), by Product Type, 2025 & 2034
- Figure 31: Rest of the World Bleeding Disorders Testing Market Value Share (%), by Product Type, 2025
- Figure 32: Rest of the World Bleeding Disorders Testing Market Value (USD million), by Indication, 2025 & 2034
- Figure 33: Rest of the World Bleeding Disorders Testing Market Value Share (%), by Indication, 2025
- Figure 34: Rest of the World Bleeding Disorders Testing Market Value (USD million), by End-user, 2025 & 2034
- Figure 35: Rest of the World Bleeding Disorders Testing Market Value Share (%), by End-user, 2025
- Figure 36: Global Bleeding Disorders Testing Market Share (%), By Company, 2025
